The ERA4TB project will host a session on lysyl transfer RNA synthetase as a novel drug target for tuberculosis. In addition, their scientific leader, Stewart Cole, Institut Pasteur will provide a keynote in the session “Applying New Technologies and Recent Learnings From TB Drug Discovery and Development, Towards Next Generation Treatments.”

Find out more here.